Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.
Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C. Micheli F, et al. Among authors: cavallini p. Bioorg Med Chem. 2016 Apr 15;24(8):1619-36. doi: 10.1016/j.bmc.2016.02.031. Epub 2016 Feb 27. Bioorg Med Chem. 2016. PMID: 26951894
2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester and structure-activity relationships.
Micheli F, Di Fabio R, Bordi F, Cavallini P, Cavanni P, Donati D, Faedo S, Maffeis M, Sabbatini FM, Tarzia G, Tranquillini ME. Micheli F, et al. Among authors: cavallini p. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2113-8. doi: 10.1016/s0960-894x(03)00396-2. Bioorg Med Chem Lett. 2003. PMID: 12798316
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists.
Micheli F, Bacchi A, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Gehanne S, Kajbaf M, Marchió L, Nola S, Oliosi B, Pellacani A, Perdonà E, Sava A, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C. Micheli F, et al. Among authors: cavallini p. J Med Chem. 2016 Sep 22;59(18):8549-76. doi: 10.1021/acs.jmedchem.6b00972. Epub 2016 Sep 9. J Med Chem. 2016. PMID: 27564135
Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.
Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C, Beaver J, Rabiner EA, Micheli F, Heidbreder C, Andorn A, Merlo Pich E, Bani M. Mugnaini M, et al. Among authors: cavallini p. Neuropsychopharmacology. 2013 Jan;38(2):302-12. doi: 10.1038/npp.2012.171. Epub 2012 Sep 12. Neuropsychopharmacology. 2013. PMID: 22968817 Free PMC article.
Studies on the novel anti-staphyloccal compound nematophin.
Kennedy G, Viziano M, Winders JA, Cavallini P, Gevi M, Micheli F, Rodegher P, Seneci P, Zumerle A. Kennedy G, et al. Among authors: cavallini p. Bioorg Med Chem Lett. 2000 Aug 7;10(15):1751-4. doi: 10.1016/s0960-894x(00)00331-0. Bioorg Med Chem Lett. 2000. PMID: 10937740
The identification of novel orally active mGluR5 antagonist GSK2210875.
Pilla M, Andreoli M, Tessari M, Delle-Fratte S, Roth A, Butler S, Brown F, Shah P, Bettini E, Cavallini P, Benedetti R, Minick D, Smith P, Tehan B, D'Alessandro P, Lorthioir O, Ball C, Garzya V, Goodacre C, Watson S. Pilla M, et al. Among authors: cavallini p. Bioorg Med Chem Lett. 2010 Dec 15;20(24):7521-4. doi: 10.1016/j.bmcl.2010.09.120. Epub 2010 Nov 2. Bioorg Med Chem Lett. 2010. PMID: 21051228
Caldesmon: anomalous electrophoretic behaviour in polyacrylamide gel.
Cavanni P, Cavallini P, Ratti E, Gaviraghi G, Dalla Libera L. Cavanni P, et al. Among authors: cavallini p. Biochem Biophys Res Commun. 1989 Apr 14;160(1):174-80. doi: 10.1016/0006-291x(89)91637-9. Biochem Biophys Res Commun. 1989. PMID: 2712828
28 results